Created in 2002, the CIPA is a department of the UPS 44 TAAM (Transgenesis and Archiving of Animal Models) situated on the CNRS campus in Orléans.
Its mission is to provide services and R&D in the field of imaging, for the academic and scientific community and various industrial partnerships. Its areas of expertise are oncology, infectiology, inflammation, and the vectorisation of medicinal products
The CIPA is also positioned as a national and European resource for imaging, serving biological, biomedical and pharmaceutical research.
As a consequence of the service activities offered by the CIPA, in biomedical research as well as for the pharmaceutical industry, regulatory preclinical studies are carried out to investigate the efficiency and safety of new drugs. This activity requires securing of the data, which is foreseen in the technical specifications of the equipment, according to the FDA standard: 21 CFR Part 11.
The drug regulatory agencies such as the Food and Drug Administration (FDA) and the European Medicines Agency (EMEA) require the data obtained during preclinical safety tests to have full traceability of all recordings and electronic signatures.